Showing results (351-360 of 450) with videos related to
Sort By:
Pageof 45
Patient Experience Journal|June 24, 2021
A Sociotechnical Systems Approach Toward Tailored Design for Personal Health Information ManagementNicole E Werner, Michelle Tong, Daniel Nathan-Roberts, et al.Biomed Research International|June 12, 2015
Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKDZahraa Mohammed-Ali, Gaile L Cruz, Chao Lu, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 4, 2003
A re-evaluation of the biokinetics of zirconium in humansI Veronese, A Giussani, M C Cantone, et al.Nursing Outlook|November 28, 2009
Quality and safety in graduate nursing education: Cross-mapping QSEN graduate competencies with NONPF's NP core and practice doctorate competenciesJoanne M Pohl, Carol Savrin, Kathryn Fiandt, et al.Pediatrics|February 9, 2026
Medical Device Design Flaws for Children With Medical Complexity at HomePeter Walsh, Sofia Seewald, Leo Castillo, et al.International Journal of Radiation Oncology, Biology, Physics|May 28, 2013
Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancerMichael E Werner, Natalie D Cummings, Manish Sethi, et al.Biosensors & Bioelectronics|February 5, 2008
Ceramic-based multisite microelectrode arrays for simultaneous measures of choline and acetylcholine in CNSJason J Burmeister, Francois Pomerleau, Peter Huettl, et al.Journal of Visualized Experiments : Jove|October 5, 2011
Formulation of diblock polymeric nanoparticles through nanoprecipitation techniqueShrirang Karve, Michael E Werner, Natalie D Cummings, et al.International Journal of Radiation Oncology, Biology, Physics|February 26, 2021
Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 StudyIrving Kaplan, Glenn J Bubley, Rupal S Bhatt, et al.Plos One|January 14, 2014
4-Phenylbutyrate inhibits tunicamycin-induced acute kidney injury via CHOP/GADD153 repressionRachel E Carlisle, Elise Brimble, Kaitlyn E Werner, et al.Pageof 45